Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Chicken TACSTD2

Cat.No. : TACSTD2-5053C
Product Overview : Recombinant Chicken TACSTD2 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Chicken
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 eu per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC.
Storage Buffer : PBS buffer
Gene Name : TACSTD2 tumor-associated calcium signal transducer 2 [ Gallus gallus (chicken) ]
Official Symbol : TACSTD2
Gene ID : 772378
Protein Refseq : NP_001264605

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (5)

Ask a question
What diagnostic techniques are used to assess TACSTD2 levels in cancer patients? 11/29/2022

Immunohistochemistry and PCR-based assays are common techniques to measure TACSTD2 expression in cancer tissues.

How does TACSTD2 contribute to cancer metastasis? 05/17/2020

TACSTD2 promotes cancer cell migration and invasion, leading to metastasis by interacting with various signaling pathways.

Are there clinical trials involving TACSTD2-targeted therapies for cancer treatment? 11/06/2018

Yes, there are ongoing clinical trials testing TACSTD2-targeted therapies, including antibody-drug conjugates and immunotherapies.

What are the potential side effects of TACSTD2-targeted therapies? 09/29/2017

Common side effects can include fatigue, nausea, diarrhea, and skin rashes, similar to other cancer treatments.

Are there any targeted therapies that focus on TACSTD2? 04/30/2017

Yes, monoclonal antibodies and antibody-drug conjugates targeting TACSTD2 are being investigated for cancer treatment.

Customer Reviews (3)

Write a review
Reviews
06/05/2020

    In addition to its advantages in trials, the manufacturer of the TACSTD2 protein offers exceptional support to researchers.

    06/11/2018

      Their team of technical experts possess deep knowledge and expertise regarding the protein, ensuring that researchers receive accurate and timely assistance.

      01/24/2018

        the TACSTD2 protein has been extensively studied and validated in various experimental applications.

        Ask a Question for All TACSTD2 Products

        Required fields are marked with *

        My Review for All TACSTD2 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends